3 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Selected Clinical ... inhibitors in CVD ... SGLT2 #inhibitors #EBM ... visualabstract #table ... #CVD #CKD
Characteristics of Common Lipid Disorders
Polygenic hypercholesterolemia
Atherogenic dyslipidemia
 • Frequently accompanied by central obesity or diabetes
Familial hypercholesterolemia,
history of premature CHD ... individuals exhibit CHD ... Family history of CHD ... Family history, CHD ... #table #defects
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... factors: Age>60, CKD ... , CHF, high rate ... Reactions #hematology #diagnosis ... #comparison #table